Pharmacist intervention through protocol-based pharmacotherapy management is effective to ensure safety in invasive procedures for chronic liver disease

Abstract Background The risk of hemorrhagic complications in patients with chronic liver disease during invasive procedures should be considered. Patients with low platelet counts were administered platelet products prior to procedures based on a physician's judgment. However, there are no stan...

Full description

Bibliographic Details

Published in:	Journal of Pharmaceutical Health Care and Sciences
Main Authors:	Yuuka Shibata, Yuki Koga, Yuki Sato, Emiko Mashida, Tomokazu Kawaoka, Eisuke Murakami, Kei Amioka, Yusuke Johira, Kensuke Naruto, Takanori Taogoshi, Tomoharu Yokooji, Masataka Tsuge, Hiroaki Matsuo
Format:	Article
Language:	English
Published:	BMC 2025-08-01
Subjects:	Chronic liver disease Protocol-based pharmacotherapy management Platelet products Thrombocytopenia Thrombopoietin receptor agonist
Online Access:	https://doi.org/10.1186/s40780-025-00456-z